Delivery Order SPE2DB22D3011-SPE2DB25FP9XD

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4564731036 RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $11,453.75 and an ultimate completion date of May 29, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,228.34 firm fixed-price delivery order is for the supply of 4563080820 - RIFAMPIN 300 MG CAPSULE UD 100S, with a performance period through December 13, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.31 firm fixed-price delivery order contract is for the supply of RIFAMPIN 300 MG CAPSULE 30S, a critical pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) to provide RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The $2,289.52 firm fixed-price delivery order has a completion date of May 23, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,110.28, is a Firm Fixed Price Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 60S, a generic pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,968.32 firm fixed price delivery order is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a critical pharmaceutical product. The contract has a completion date of November 15, 2024 and was awarded on November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,078.06 firm fixed-price delivery order covers the supply of RIFAMPIN 300 MG CAPSULE 60S, a critical pharmaceutical product, to support federal healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $30,254.29 firm fixed-price delivery order is for the procurement of 4565173942 RIFAMPIN 300 MG CAPSULE 60S, with a completion date of July 18, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award is for the delivery of 4,567,279,694 units of RIFAMPIN 300 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The contract, valued at $4,791.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award, with an ID of SPE2DB22D3011|SPE2DB24FQ1BM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,028.28 firm fixed-price delivery order is for the supply of 4564514313 - RIFAMPIN 300 MG CAPSULE 60S, with a completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP9XD
    Delivery Order

This federal contract award, identified as SPE2DB22D3011|SPE2DB25FP9XD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $25,934.76. The contract is for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product, with a period of performance extending through March 17, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/13/25, 9:53 AM